Swiss biotech firm Anokion grabs $40 mln


Anokion SA, a Swiss biotechnology company, has secured $40 million in funding. The investors included Versant Ventures, Novartis Venture Fund, Novo Ventures and Celgene. Also, Anokon has acquired Kanyos Bio Inc. No financial terms were disclosed.

Source: Press Release